Latest filing published 22 Aug 2012 for Seelos Therapeutics, INC., €3,315.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Edward M. Cox: trading record in brief
Edward M. Cox is a declared insider of Seelos Therapeutics, Inc., with filings sourced from SEC (Form 4). In total, 9 filings cover trades dated from 11 January 2010 to 20 August 2012.
No open-market sale appears; the market trades are 1 purchase worth €3,315. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 6 share grants. 2012 to date brings 1 purchase and no sales.
On 22 August 2012 came the latest disclosure, an open-market purchase for €3,315 in Seelos Therapeutics, Inc. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Edward M. Cox
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,500 shares@ US$2.73Common StockSEC:0001144204-12-047519:0Canonical exit: 18 Nov 2012 (T+90)
- 13,574 sharesCommon StockSEC:0001144204-12-017853:0
- 10,362 sharesCommon StockSEC:0001144204-11-031017:0
- 18,749 sharesCommon StockSEC:0001144204-11-031017:1
- 60,935 sharesCommon StockSEC:0001144204-10-038205:0
- 52,594 shares@ US$2.52Common StockSEC:0001144204-10-035238:0
- 75,000 shares0Common StockSEC:0001144204-10-019834:0
- 324,327 shares@ US$0.168Common StockSEC:0001144204-10-014033:0
- 52,819 shares@ US$0.168Common StockSEC:0001144204-10-001905:0
9 of 9 declarations
